Remedies for retina and choroid diseases containing steroids as the active ingredient

Abstract

An object of the present invention is to provide therapeutic agents for retinochoroidal disorders comprising a steroid as an active ingredient and having improved effects and dosage forms for treating the retinochoroidal disorders whereby the steroid can be easily administered. The present invention relates to therapeutic agents for the retinochoroidal disorders comprising betamethasone or hydrocortisone as an active ingredient and to subconjunctival injections comprising the steroid as an active ingredient.

Description

technical field [0001] The present invention relates to a therapeutic agent for retinal and choroidal diseases with specific steroids, namely betamethasone and hydrocortisone, as active ingredients, and a subconjunctival injection for treating retinal and choroidal diseases with steroids as active ingredients. Background technique [0002] Retinal and choroidal diseases are refractory diseases that lead to blindness, among which age-related macular degeneration, diabetic retinopathy and proliferative vitreoretinopathy are the main retinal and choroidal diseases. [0003] Age-related macular degeneration (hereinafter referred to as [AMD]) is a disease of unknown cause that occurs in the macula with age. It is commonly seen in people over the age of 50, and it has attracted attention in recent years as a major cause of poor vision and blindness in the elderly. AMD includes the following types: the exudative type in which new blood vessels derived from the choroid grow in the ...

AI Technical Summary

Problems solved by technology

Although the methods of intravitreal injection and intraocular capsule injection have been advocated, these methods depend on the skills of doctors to a large extent, and because of the large obstacles of ocular tissues, it also brings pain to patients. came considerable pain